Journal of Human Reproductive Science
Home Ahead of Print Current Issue Archives
   Bookmark this page Print this page Email this page Small font sizeDefault font size Increase font size    Users online: 1460


 
ORIGINAL ARTICLE Table of Contents   
Year : 2015  |  Volume : 8  |  Issue : 2  |  Page : 86-92
Impact of different controlled ovarian stimulation protocols on the physical and psychological burdens in women undergoing in vitro fertilization/intra cytoplasmic sperm injection


1 Infertility Institute and Research Center, Hyderabad, Telangana, India
2 Associate Director Medical Affairs, Jaslok Hospital, Mumbai, Maharashtra, India
3 Department of Obstetrics and Gynaecology, Kasturba Medical College, Manipal, Karnataka, India
4 Director of Assisted Reproduction and Genetics, Jaslok Hospital, Mumbai, Maharashtra, India
5 Executive Director Nova IVI Fertility Specialty, Ahmedabad, Gujarat, India

Correspondence Address:
Ashish Ramesh Birla
Organon India Pvt. Ltd., 8th Floor, Platina Bldng., Plot C-59, G.Block, Bandra Kurla Complex, Bandra East, Mumbai - 400 098, Maharashtra
India
Login to access the Email id

Source of Support: This study was sponsored by Organon India Pvt. Ltd a subsidiary of Merck & Co., Inc. Kenilworth N.J, USA, Conflict of Interest: None


DOI: 10.4103/0974-1208.158615

Clinical trial registration CTRI/2012/07/002770

Rights and Permissions

Context: Infertility treatment involves a considerable amount of physical and psychological burden which may impact the outcome. Aim: The objective was to understand the amount of physical and psychological burden in women undergoing their first in vitro fertilization (IVF)/intra cytoplasmic sperm injection (ICSI) cycles. Setting and Design: Multi-center, prospective, parallel, observational study. Materials and Methods: The study was conducted across 12 IVF centers in India. A total of 692 women undergoing controlled ovarian stimulation as a part of the first cycle IVF/ICSI completed the trial. Women were recruited in 2 groups based on type of treatment (Group A - gonadotropin-releasing hormone [GnRH] antagonist; Group B - GnRH agonist) and were asked to fill questionnaires during the 2 treatment visits. Results: The mean changes between Visit 1 (baseline) and Visit 2 in anxiety and depression (Hospital Anxiety and Depression Scale) scores in Group A for anxiety and depression were −0.5 (3.67), −0.1 (3.57) respectively and for Group B were −0.4 (3.68), 0.1 (3.67) respectively, which was not statistically significant. In Group A, the mean (±standard deviation [SD]) Hopkins Symptom Check List (HSCL) score was 17.9 (±5.17) in visit 1 and 19.1 (±5.45) Visit 2. The change between visits was 1.1 (P < 0.0001) with higher score reflecting higher somatic distress symptoms. In Group B, the mean (±SD) HSCL score was 18.2 (±5.19) in Visit 1 and 18.8 (±5.23) in visit 2. The change between visits was 0.6 (P < 0.0014). The difference of the mean change in physical burden between Group A and Group B was not statistically significant. Conclusion: A significant impact in both treatment protocols with respect to the physical burden was found between Visit 1 and Visit 2 but no difference in physical or psychological burden between the two treatment groups was observed.


[FULL TEXT] [PDF]*
Print this article  Email this article
    

  Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
  Related articles
   Citation Manager
  Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed2513    
    Printed34    
    Emailed0    
    PDF Downloaded118    
    Comments [Add]    

Recommend this journal